Dal Alert!

Receive alerts from Dalhousie by text message.

X

» Go to news main

Zebrafish lead Dalhousie researchers to important discoveries in prostate cancer and leukemia

Posted by Melanie Jollymore on November 22, 2017 in News
Zebrafish have helped Dal researchers, Dr. Jason Berman, Nicole Melong and Dr. Graham Dellaire, shed light on a potentially deadly cardiac side effect of a new drug meant to prolong life in advanced prostate cancer. (Jollymore photos)
Zebrafish have helped Dal researchers, Dr. Jason Berman, Nicole Melong and Dr. Graham Dellaire, shed light on a potentially deadly cardiac side effect of a new drug meant to prolong life in advanced prostate cancer. (Jollymore photos)


The zebrafish, a four- to six-centimetre minnow, has led researchers to remarkable revelations about the development and treatment of human disease.

These include a surprising discovery about prostate cancer, and a hopeful one for childhood leukemia, in studies led by Dr. Graham Dellaire and Dr. Jason Berman at Dalhousie.

Dr. Dellaire’s main interest is the treatment of solid tumours found in breast, lung and prostate cancer. He sees zebrafish as an important vehicle for developing personalized cancer therapies.

“If we can inject the embryo with cells from a human tumour and then introduce a range of chemotherapy treatments, we can figure out which one works best for a particular patient,” he says. 

Read more on Dal News.